Back to VYNE

ACORN CAPITAL ADVISORS, LLC → VYNE

ACORN CAPITAL ADVISORS, LLC VYNE Position History

VYNE Therapeutics Inc • Healthcare

Quarters held
4
Latest value
$721K
Q3 2026
Peak value
$721K
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$827
Q1 2026$855
Q2 2026$926
Q3 2026$721K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$721K32.0K——
Q2 2026$9261.4K——
Q1 2026$8551.4K——
Q4 2025$8271.4K——

Other funds holding VYNE

Other ACORN CAPITAL ADVISORS, LLC positions

CGON

CG ONCOLOGY INC

$80.4M
CGON

CG ONCOLOGY INC

$80.2M
CGON

CG ONCOLOGY INC

$76.6M
URGN

UROGEN PHARMA LTD

$67M
URGN

UROGEN PHARMA LTD

$61.6M
CGON

CG ONCOLOGY INC

$47M
TRVI

TREVI THERAPEUTICS INC

$40M
CGC

CANDEL THERAPEUTICS INC

$36.5M